All Stories

  1. Study of the time-relationship of the mechano-electrical interaction in an animal model of tetralogy of Fallot: implications for the risk assessment of ventricular arrhythmias
  2. Progression of incomplete toward complete left bundle branch block: A clinical and electrocardiographic analysis
  3. Balancing the risks of adverse events and optimal programming of implantable cardioverter-defibrillators
  4. Commentary: Interventricular Differences in Action Potential Duration Restitution Contribute to Dissimilar Ventricular Rhythms in ex vivo Perfused Hearts
  5. Failure to detect life‐threatening arrhythmias in ICDs using single‐chamber detection criteria
  6. Gender differences in electro-mechanical characteristics of left bundle branch block: Potential implications for selection and response of cardiac resynchronization therapy
  7. P1229Different scenarios leading to inappropriate therapy inhibition in single chamber ICD detection programming
  8. Relation between electrical and mechanical dyssynchrony in patients with left bundle branch block: An electro- and vectorcardiographic study
  9. Accuracy of computer-calculated and manual QRS duration assessments: Clinical implications to select candidates for cardiac resynchronization therapy
  10. Biventricular Paced QRS Area Predicts Acute Hemodynamic CRT Response Better Than QRS Duration or QRS Amplitudes
  11. Shock-refractory ventricular fibrillation in a patient implanted with a left ventricular assist device
  12. Undetected ventricular fibrillation in a single-chamber implantable cardioverter-defibrillator: When the far-field channel sees more than the intraventricular channel
  13. Diagnostic accuracy of a novel method for detection of acute transmural myocardial ischemia based upon a self-applicable 3-lead configuration
  14. The electrocardiographic characteristics of septal flash in patients with left bundle branch block
  15. ECG from Basics to Essentials
  16. Alternans of the Ventricular Electrogram in Patients with an Implanted Cardioverter-Defibrillator
  17. Different Methods to Measure QRS Duration in CRT Patients: Impact on the Predictive Value of QRS Duration Parameters
  18. Electrical Atrial Alternans Recorded by Cardiac Rhythm Devices during Atrial Flutter
  19. Alternans-Induced ICD Therapy
  20. Variability in interpretation of the electrocardiogram in young athletes: an unrecognized obstacle for electrocardiogram-based screening protocols
  21. Bipolar electrograms characteristics at the left atrial–pulmonary vein junction: Toward a new algorithm for automated verification of pulmonary vein isolation
  22. ICD Sees What You Do Not See: How Does It Beat You?
  23. Atrioventricular Block Precipitated by Isoproterenol
  24. Mobitz Type II Second-Degree Atrioventricular Block during Dobutamine Stress Echocardiography. True or False?
  25. Novel Algorithmic Methods in Mapping of Atrial and Ventricular Tachycardia
  26. Mapping and Ablation of a Narrow QRS Tachycardia in a Patient with Ischemic Cardiomyopathy
  27. Juxtaposition of Automatic Mode Switching and Tachycardia‐Terminating Algorithms in a Dual‐Chamber Implantable Cardioverter Defibrillator
  28. A review of the confirmation algorithm and related timing cycles of St. Jude ICDs
  29. A “Shocking” Case Rectified
  30. Dissimilar ventricular rhythms: Implications for ICD therapy
  31. Automatic mode switching of a dual chamber implantable cardioverter–defibrillator induced by a ventricular escape rhythm
  32. Paroxysmal atrioventricular block precipitated by an atrial premature beat. What is the mechanism?
  33. Phantom crosstalk
  34. Limitations of the negative concordance pattern in the diagnosis of broad QRS tachycardia
  35. Implantable Cardioverter-Defibrillators: Is There Life after Death?
  36. Unusual Cause of Far-Field Atrial Sensing by the Ventricular Lead of a Dual Chamber Defibrillator. What is the Mechanism?
  37. Device Diagnosis of Pacemaker-Mediated Tachycardia: True or False?
  38. Functional Atrial Undersensing Associated with Switching to a Tracking Mode of Pacing
  39. Pacemaker repetitive nonreentrant ventriculoatrial synchrony. Why did automatic mode switching occur?
  40. Rise in ICD Shock Impedance: Lead Fracture or Death?
  41. Unusual cause of desynchronization in a cardiac resynchronization device
  42. Erroneous automatic pacemaker arrhythmia diagnosis: Is it malfunction or a design limitation?
  43. Atrial Undersensing and Cycle Prolongation Related to Automatic Mode Switching: What is the Mechanism?
  44. Pacemaker-mediated tachycardia initiated by an atrioventricular search algorithm to minimize right ventricular pacing
  45. P-wave locking in the postventricular atrial refractory period of cardiac resynchronization devices
  46. Ventricular Pacing Faster than the Upper Rate in an ICD Programmed to the DDD Mode
  47. Escape-echo bigeminy
  48. Using devices with a variable postventricular atrial refractory period for cardiac resynchronization
  49. Significance of Missing Telemetered Markers in Implanted Cardioverter-Defibrillators
  50. Atrial lead malfunction presenting as new onset pacemaker-mediated tachycardia
  51. Automatic Mode Switching Induced by a Ventricular Bigeminal Rhythm: What Is the Mechanism?
  52. Unusual Manifestation of Upper Rate Limitation in a Dual-Chamber ICD
  53. Termination of pacemaker-mediated tachycardia by a critically timed atrial extrasystole
  54. Reappraisal of the Traditional Wenckebach Phenomenon with a Modified Ladder Diagram
  55. Impact of increasing current drain in a pacemaker operating during activation of the elective replacement indicator
  56. Committed function for the first delivered shock of an uncommitted implantable cardioverter-defibrillator
  57. Histogram Analysis: A Novel Method to Detect and Differentiate Fractionated Electrograms During Atrial Fibrillation
  58. Cardiac Pacemakers and Resynchronization Step-by-Step
  59. Narrow QRS Tachycardia With Double His Potentials: What Is the Mechanism?
  60. Complex Manifestations of an Automatic Mode Switching Algorithm
  61. Confusing ICD Terminology: Refractory and Blanking Periods
  62. Harmfull effects of long-term right ventricular pacing
  63. Silent Lead Malfunction Detected Only During Defibrillator Replacement
  64. Cardiac Pacemakers Step by Step
  65. Advances in cardiac pacing
  66. Internal cardioversion
  67. Morphology Discrimination of Ventricular Tachycardia from Supraventricular Tachycardia by Implantable Cardioverter Defibrillators: Are Implantable Cardioverter Defibrillators Really Starting to Look at Arrhythmias with the Eyes of a Cardiologist?
  68. Supraventricular Tachycardia with Alternating Cycle Length: What is the Mechanism?
  69. A Reappraisal of Pacemaker Timing Cycles Pertaining to Automatic Mode Switching
  70. Rate Adaptive Dual Chamber Pacing: Inappropriate Rate Response due to Pseudomalfunction of the QT Biosensor
  71. Propafenone for Conversion and Prophylaxis of Atrial Fibrillation
  72. Review of the Reviewer
  73. Cardiac Pacing and Electrophysiology
  74. Clinical utility of telemetered electrograms in pacemakers and ICDs
  75. Voltage Dip in Pacemaker Battery Supply: A New Cause of Pacemaker Mediated Tachycardia
  76. How to face ‘the faces’ of Cardiac Pacing
  77. Efficacy and safety of intravenous sotalol for termination of paroxysmal supraventricular tachycardia
  78. Hemodynamics in Daily Practice
  79. Effect of the infusion of magnesium sulfate during atrial pacing on ECG intervals, serum electrolytes, and blood pressure
  80. The Superfast Atrial Recharge Pulse: A Cause of Pectoral Muscle Stimulation in Patients Equipped with a Unipolar DDD Pacemaker
  81. Delayed Elimination of Digoxin Antidotum Determined by Radioimmunoassay
  82. Sodium Channel Block by a Potent, New Antiarrhythmic Agent, Transcainide, in Guinea Pig Ventricular Myocytes
  83. Pacing and Sensing: How Can One Electrode Fulfill Both Requirements?
  84. Effects of intravenous sotalol, aprindine and the combination of sotalol and aprindine on chronic high frequency ventricular arrhythmias in man
  85. Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718)
  86. Effect of sotalol, aprindine and their combination on maximum upstroke velocity of action potential in guinea-pig papillary muscle
  87. Prediction of Wenckebach Behavior and Block Response in DDD Pacemakers.
  88. Effect of sotalol, aprindine and the combination aprindine—sotalol on monophasic action potential duration
  89. Simultaneous Recording of Atrial and Ventricular Monophasic Action Potentials: Monophasic Action Potential Duration During Atrial Pacing, Ventricular Pacing, and Ventricular Fibrillation
  90. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias
  91. Inhibition of On Demand Pacemakers by Magnet Waving
  92. Potential Causes of Spurious Programming: Report of a Case
  93. Clinical experience of encainide (MJ 9067): A new anti-arrhythmic drug
  94. Die Bedeutung der endomyokardialen Katheterbiopsie für die Diagnostik und die Beurteilung der Prognose der kongestiven Kardiomyopathie
  95. Hypertrophic non-obstructive cardiomyopathy caused by disorder of the myofiber texture
  96. Successful Treatment of Pacemaker-Induced Ventricular Fibrillation
  97. Are patients with essential hypertension and low renin protected against stroke and heart attack?
  98. Prognosis in Low Renin Hypertension
  99. Arterial blood supply of the atrioventricular node and main bundle.
  100. New Pacing Algorithms and Functions in CRT Devices